Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Darktrace in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $7.61.
Current Consensus is
N/A
The current consensus among 0 investment analysts is to n/a stock in Darktrace. This N/A consensus rating has held steady for over two years.
Darktrace plc, together with its subsidiaries, engages in the development and sale of cyber-threat defense technology solutions in the United Kingdom, the United States, Europe, and internationally. Its products include Darktrace PREVENT, an attack surface management that continuously monitors attack surface for risks, high-impact vulnerabilities, and external threats; and Darktrace DETECT, which analyzes thousands of metrics to reveal subtle deviations that may signal an evolving threat, including unknown techniques and novel malware, as well as installs in minutes, identifies threats, and avoids disruption. The company's products also include Darktrace RESPOND that works autonomously to disarm attacks whenever they occur and reacts to threats in seconds, as well as works 24/7 as it frees up security teams and resources; and Darktrace HEAL, which enables organizations to restore business affected by cyber-attacks to trusted operational states through AI assistance. The company was formerly known as Srenoog plc and changed its name to Darktrace plc in March 2021. Darktrace plc was founded in 2013 and is headquartered in Cambridge, the United Kingdom.
Read More
